BCL2 and neoplasm: To investigate the underlying antitumor mechanism of TMEA against SW620 tumor xenografts in vivo, we investigated the effects of TMEA on the expression of CD31, Bcl-2, Bax, and caspase-3 and compared to that of 5-FU treatment.